Keytruda May Help Fight Tough-to-Treat Lung Cancer

SATURDAY, Dec. 19, 2015 — The immune therapy drug Keytruda (pembrolizumab) may extend the lives of people with advanced lung cancer, a new study finds.
Keytruda is commonly used to treat other tumor types, and made headlines recently after it…
Source: Topamax